Jianqiu Tang1, Qiaoxia Zhou1, Fen Zhao2, Fulin Wei1, Jian Bai2, Yuping Xie2, Ying Huang1. 1. West China School of Preclinical and Forensic Medicine, Sichuan University Chengdu 610041, Sichuan Province, China. 2. Department of Oncology, Chengdu First People's Hospital Chengdu 610041, Sichuan Province, China.
Abstract
BACKGROUND: Published data regarding the associations between glutathione S-transferase (GST) T1, M1 and P1 polymorphisms and breast cancer risk are inconclusive. The aim of this study is to comprehensively evaluate the genetic risk of GST genes for breast cancer. MATERIALS AND METHODS: A systematic literature search was carried out in Pubmed, Medline (Ovid), Embase, CBM, CNKI, Weipu, and Wanfang database, covering all publications (last search was performed on May 20, 2015). Statistical analysis was performed using Revman 5.2 and STATA 12.0 softwares. RESULTS: A total of 12,035 cases and 13,911 controls in 34 case-control studies were included in this meta-analysis. The results suggested that the GSTM1 and GSTP1 polymorphisms can obviously increase the risk of breast cancer in Asian population (odds ratio (OR) = 1.18, 95% confidence interval (CI) = 1.04-1.33, P = 0.008 and OR = 1.23, 95% CI = 1.07-1.41, P = 0.003, respectively), especially in East Asian (OR = 1.14, 95% CI = 1.01-1.27, P = 0.03 and OR = 1.15, 95% CI = 1.03-1.28, P = 0.01, respectively) and hospital-based case-control study (HCC) group (OR = 1.32, 95% CI = 1.11-1.56, P = 0.001 and OR = 1.38, 95% CI = 1.03-1.84, P = 0.03, respectively), while the association between GSTT1 null genotype and breast cancer risk is not significant (OR = 1.08, 95% CI = 0.93-1.25, P = 0.3). CONCLUSIONS: This meta-analysis indicated that the GSTM1 and GSTP1 polymorphisms might significantly contribute to breast cancer susceptibility in Asian population, especially in East Asian, while the GSTT1 polymorphism might not be associated with breast cancer.
BACKGROUND: Published data regarding the associations between glutathione S-transferase (GST) T1, M1 and P1 polymorphisms and breast cancer risk are inconclusive. The aim of this study is to comprehensively evaluate the genetic risk of GST genes for breast cancer. MATERIALS AND METHODS: A systematic literature search was carried out in Pubmed, Medline (Ovid), Embase, CBM, CNKI, Weipu, and Wanfang database, covering all publications (last search was performed on May 20, 2015). Statistical analysis was performed using Revman 5.2 and STATA 12.0 softwares. RESULTS: A total of 12,035 cases and 13,911 controls in 34 case-control studies were included in this meta-analysis. The results suggested that the GSTM1 and GSTP1 polymorphisms can obviously increase the risk of breast cancer in Asian population (odds ratio (OR) = 1.18, 95% confidence interval (CI) = 1.04-1.33, P = 0.008 and OR = 1.23, 95% CI = 1.07-1.41, P = 0.003, respectively), especially in East Asian (OR = 1.14, 95% CI = 1.01-1.27, P = 0.03 and OR = 1.15, 95% CI = 1.03-1.28, P = 0.01, respectively) and hospital-based case-control study (HCC) group (OR = 1.32, 95% CI = 1.11-1.56, P = 0.001 and OR = 1.38, 95% CI = 1.03-1.84, P = 0.03, respectively), while the association between GSTT1 null genotype and breast cancer risk is not significant (OR = 1.08, 95% CI = 0.93-1.25, P = 0.3). CONCLUSIONS: This meta-analysis indicated that the GSTM1 and GSTP1 polymorphisms might significantly contribute to breast cancer susceptibility in Asian population, especially in East Asian, while the GSTT1 polymorphism might not be associated with breast cancer.
Entities:
Keywords:
GSTM1; GSTP1; GSTT1; breast cancer; meta-analysis; polymorphism; susceptibility
Authors: Asma Sohail; Nazia Kanwal; Muhammad Ali; Sobia Sadia; Ahmed Ijaz Masood; Faheem Ali; Furhan Iqbal; Neil Crickmore; Rehan Sadiq Shaikh; Ali H Sayyed Journal: Environ Toxicol Pharmacol Date: 2012-12-16 Impact factor: 4.860
Authors: Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray Journal: Int J Cancer Date: 2014-10-09 Impact factor: 7.396
Authors: Angela Galardi; Marta Colletti; Chiara Lavarello; Virginia Di Paolo; Paolo Mascio; Ida Russo; Raffaele Cozza; Antonino Romanzo; Paola Valente; Rita De Vito; Luisa Pascucci; Hector Peinado; Angel M Carcaboso; Andrea Petretto; Franco Locatelli; Angela Di Giannatale Journal: Cancers (Basel) Date: 2020-06-12 Impact factor: 6.639